Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase 11 inhibitors
1997

Effects of Polyamine Inhibitors on Cancer Cell Sensitivity

Sample size: 10000 publication Evidence: moderate

Author Information

Author(s): MA Desiderio, D Bergamaschi, E Mascellani, P De Feudis, E Erba, M D'Incalci

Primary Institution: Istituto di Patologia Generale, Universita degli Studi di Milano and Mario Negri Institute

Hypothesis

Does the depletion of spermine affect the cytotoxicity of anti-cancer agents in ovarian cancer cells?

Conclusion

Depleting spermine reduces the effectiveness of DNA topoisomerase II inhibitors but does not affect alkylating agents.

Supporting Evidence

  • Depleting spermine did not change the effectiveness of alkylating agents.
  • Spermine depletion led to reduced sensitivity to DNA topoisomerase II inhibitors.
  • Adding spermine back restored sensitivity to the inhibitors.
  • Cells accumulated in the G1 phase of the cell cycle after spermine depletion.

Takeaway

This study found that taking away a substance called spermine from cancer cells makes some cancer drugs less effective, but not all.

Methodology

The study used human ovarian cancer cells (OVCAR-3) and treated them with specific inhibitors to deplete spermine, followed by exposure to various anti-cancer drugs.

Limitations

The study primarily focused on one cell line and may not generalize to other types of cancer cells.

Participant Demographics

Human ovarian cancer cell line OVCAR-3.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication